Literature DB >> 19562242

Age-related changes in biochemical markers of bone turnover and gonadotropin levels and their relationship among Chinese adult women.

X-Y Wu1, X-P Wu, H Xie, H Zhang, Y-Q Peng, L-Q Yuan, X Su, X-H Luo, E-Y Liao.   

Abstract

UNLABELLED: The relationship between the levels of gonadotropic hormones and bone metabolism in Chinese adult women is unclear. Our research shows that a significant positive correlation exists between the levels of gonadotropic hormones and various bone turnover indicators. Follicle-stimulating hormone (FSH) has been found to have a greater influence on all types of bone turnover indicator than luteinizing hormone (LH). Further, FSH has a greater influence on bone formation indicators than on bone resorption indicators.
INTRODUCTION: The aim of this study was to investigate the relationship between serum FSH and LH and biochemical markers of bone turnover in native Chinese adult women.
METHODS: We conducted a cross-sectional study of 694 healthy Chinese women aged between 20 and 82 years. Serum FSH, LH, bone-specific alkaline phosphatase (BAP), osteocalcin (OC), N-terminal telopeptides of type I collagen, C-terminal telopeptides of type I collagen, urinary NTX, urinary CTX, and urinary deoxypyridinoline (uDPD) were determined.
RESULTS: All types of bone turnover indicator were significantly positively correlated with FSH (r = 0.164-0.626, all P = 0.000) and LH (r = 0.130-0.618, all P = 0.013-0.000). The correlation coefficient between serum FSH and BAP was the highest (r = 0.626), and that between serum FSH and uDPD was the lowest (r = 0.164). The serum gonadotropic hormone levels were higher; concentrations of bone turnover indicators were higher. The extent of the influence of FSH on various bone turnover indicators was approximately seven to 20 times greater than that of LH on these indicators. FSH could explain 43% and 22% of the changes in BAP and OC, respectively; whereas, LH could explain only 2.1% and 1.1%, respectively. FSH could explain approximately 1.9-11.8% of the changes in bone resorption indicators; however, LH had almost no effect on them.
CONCLUSIONS: Gonadotropic hormone levels are correlated with the rate of bone turnover in Chinese women: the higher the serum gonadotropic hormone levels in circulation, the higher the levels of bone turnover indicators. FSH has a greater influence on all types of bone turnover indicator than LH; moreover, it has a greater influence on bone formation indicators than on bone resorption indicators.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19562242     DOI: 10.1007/s00198-009-0943-9

Source DB:  PubMed          Journal:  Osteoporos Int        ISSN: 0937-941X            Impact factor:   4.507


  38 in total

1.  Menopausal symptoms: experience of Chinese women.

Authors:  G Zhao; L Wang; R Yan; L Dennerstein
Journal:  Climacteric       Date:  2000-06       Impact factor: 3.005

2.  FSH directly regulates bone mass.

Authors:  Li Sun; Yuanzhen Peng; Allison C Sharrow; Jameel Iqbal; Zhiyuan Zhang; Dionysios J Papachristou; Samir Zaidi; Ling-Ling Zhu; Beatrice B Yaroslavskiy; Hang Zhou; Alberta Zallone; M Ram Sairam; T Rajendra Kumar; Wei Bo; Jonathan Braun; Luis Cardoso-Landa; Mitchell B Schaffler; Baljit S Moonga; Harry C Blair; Mone Zaidi
Journal:  Cell       Date:  2006-04-21       Impact factor: 41.582

3.  Ovarian aging and bone metabolism in menstruating women aged 35-50 years.

Authors:  Fisun Vural; Birol Vural; Izzet Yucesoy; Selim Badur
Journal:  Maturitas       Date:  2005-10-16       Impact factor: 4.342

4.  FSH and bone--important physiology or not?

Authors:  Jerilynn C Prior
Journal:  Trends Mol Med       Date:  2006-12-01       Impact factor: 11.951

5.  Association between female sex hormones and biochemical markers of bone turnover in peri- and postmenopausal women.

Authors:  P Peichl; A Griesmacher; P Pointinger; R Marteau; W Hartl; W Gruber; H Bröll
Journal:  Calcif Tissue Int       Date:  1998-05       Impact factor: 4.333

6.  Hormone predictors of bone mineral density changes during the menopausal transition.

Authors:  MaryFran R Sowers; Mary Jannausch; Daniel McConnell; Roderick Little; Gail A Greendale; Joel S Finkelstein; Robert M Neer; Janet Johnston; Bruce Ettinger
Journal:  J Clin Endocrinol Metab       Date:  2006-01-10       Impact factor: 5.958

7.  Establishment of BMD reference plots and determination of peak BMD at multiple skeletal regions in mainland Chinese women and the diagnosis of osteoporosis.

Authors:  Xian-Ping Wu; Er-Yuan Liao; Hong Zhang; Peng-Fei Shan; Xing-Zhi Cao; Shi-Ping Liu
Journal:  Osteoporos Int       Date:  2003-11-04       Impact factor: 4.507

8.  The type I collagen fragments ICTP and CTX reveal distinct enzymatic pathways of bone collagen degradation.

Authors:  P Garnero; M Ferreras; M A Karsdal; R Nicamhlaoibh; J Risteli; O Borel; P Qvist; P D Delmas; N T Foged; J M Delaissé
Journal:  J Bone Miner Res       Date:  2003-05       Impact factor: 6.741

9.  Could bone tissue be a target for luteinizing hormone/chorionic gonadotropin?

Authors:  Jason P Mansell; Allen J Bailey; Sarah J Yarram
Journal:  Mol Cell Endocrinol       Date:  2007-02-14       Impact factor: 4.102

10.  Geographic differences in bone turnover: data from a multinational study in healthy postmenopausal women.

Authors:  F J Cohen; S Eckert; B H Mitlak
Journal:  Calcif Tissue Int       Date:  1998-10       Impact factor: 4.333

View more
  16 in total

1.  Further evidence that FSH causes bone loss independently of low estrogen.

Authors:  Jameel Iqbal; Harry C Blair; Alberta Zallone; Li Sun; Mone Zaidi
Journal:  Endocrine       Date:  2012-02-21       Impact factor: 3.633

Review 2.  The role of FSH and TSH in bone loss and its clinical relevance.

Authors:  Manasi Agrawal; Guangyu Zhu; Li Sun; Mone Zaidi; Jameel Iqbal
Journal:  Curr Osteoporos Rep       Date:  2010-12       Impact factor: 5.096

3.  Further evidence for direct pro-resorptive actions of FSH.

Authors:  Li Sun; Zhiyuan Zhang; Ling-Ling Zhu; Yuanzhen Peng; Xuan Liu; Jianhua Li; Manasi Agrawal; Lisa J Robinson; Jameel Iqbal; Harry C Blair; Mone Zaidi
Journal:  Biochem Biophys Res Commun       Date:  2010-02-19       Impact factor: 3.575

4.  Contribution of bone turnover markers to the variation in bone mineral density: a study in Vietnamese men and women.

Authors:  L T Nguyen; U D T Nguyen; T D T Nguyen; L T Ho-Pham; T V Nguyen
Journal:  Osteoporos Int       Date:  2018-09-08       Impact factor: 4.507

5.  Role of serum FSH measurement on bone resorption in postmenopausal women.

Authors:  Antonia García-Martín; Rebeca Reyes-García; José Miguel García-Castro; Pedro Rozas-Moreno; Fernando Escobar-Jiménez; Manuel Muñoz-Torres
Journal:  Endocrine       Date:  2011-10-01       Impact factor: 3.633

Review 6.  FSH-metabolic circuitry and menopause.

Authors:  Charit Taneja; Sakshi Gera; Se-Min Kim; Jameel Iqbal; Tony Yuen; Mone Zaidi
Journal:  J Mol Endocrinol       Date:  2019-10       Impact factor: 5.098

Review 7.  The pathophysiology of the aging skeleton.

Authors:  Farhan A Syed; Alvin C Ng
Journal:  Curr Osteoporos Rep       Date:  2010-12       Impact factor: 5.096

Review 8.  Actions of pituitary hormones beyond traditional targets.

Authors:  Mone Zaidi; Maria I New; Harry C Blair; Alberta Zallone; Ramkumarie Baliram; Terry F Davies; Christopher Cardozo; James Iqbal; Li Sun; Clifford J Rosen; Tony Yuen
Journal:  J Endocrinol       Date:  2018-03-19       Impact factor: 4.286

9.  Blocking antibody to the β-subunit of FSH prevents bone loss by inhibiting bone resorption and stimulating bone synthesis.

Authors:  Ling-Ling Zhu; Harry Blair; Jay Cao; Tony Yuen; Rauf Latif; Lida Guo; Irina L Tourkova; Jianhua Li; Terry F Davies; Li Sun; Zhuan Bian; Clifford Rosen; Alberta Zallone; Maria I New; Mone Zaidi
Journal:  Proc Natl Acad Sci U S A       Date:  2012-08-20       Impact factor: 11.205

10.  FSH, Bone Mass, Body Fat, and Biological Aging.

Authors:  Mone Zaidi; Daria Lizneva; Se-Min Kim; Li Sun; Jameel Iqbal; Maria I New; Clifford J Rosen; Tony Yuen
Journal:  Endocrinology       Date:  2018-10-01       Impact factor: 4.736

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.